Emma Recio Soler

Title: Emma Recio Soler: Innovator in Particle Size Stabilization

Introduction

Emma Recio Soler is a notable inventor based in Sant Joan Despi, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the stabilization of particle sizes for medicinal compounds. Her innovative work has the potential to enhance the efficacy of treatments for various respiratory diseases.

Latest Patents

Emma holds a patent for a process that stabilizes the particle size of micronized glycopyrronium salt, specifically glycopyrronium bromide. This invention provides a method that yields a micronized product with improved chemical and polymorphic stability, even after prolonged storage. The patent also encompasses compositions that include the stabilized glycopyrronium salt and dry powder inhaler devices, as well as capsules or blisters containing the stabilized product. The applications of her invention are particularly relevant in treating asthma, chronic obstructive pulmonary disease, cystic fibrosis, and related conditions.

Career Highlights

Emma Recio Soler is associated with Inke, S.A., where she applies her expertise in pharmaceutical development. Her work focuses on creating innovative solutions that address critical health challenges. With her patent, she has positioned herself as a key player in the pharmaceutical industry, contributing to advancements in drug formulation and delivery.

Collaborations

Emma has collaborated with esteemed colleagues such as Josep Terradas Camins and Josep Maria Carulla Oliver. These partnerships have fostered a collaborative environment that enhances the research and development of innovative pharmaceutical solutions.

Conclusion

Emma Recio Soler is a pioneering inventor whose work in particle size stabilization has significant implications for the pharmaceutical industry. Her contributions not only advance scientific knowledge but also improve treatment options for patients with respiratory diseases.